Xerophthalmia clinical trials
The registry lists 20 studies for Xerophthalmia across more than 10 countries. 8 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-10-22.
Keep track of what changes. Save the Xerophthalmia studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesWho runs them
Taipei Veterans General Hospital, Taiwan (4) · Dompé Farmaceutici S.p.A (2) · Avizor SA (1) · Huons Co., Ltd. (1) · Yune Zhao (1) · Université de Montréal (1) · Clinique Trenel (1) · Singapore National Eye Centre (1)
Who these studies take
Of the 4 Xerophthalmia studies recruiting now, 1 (25%) set no upper age limit and 2 (50%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (25%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 2 (50%) | 2 (50%) |
| 30 | 3 (75%) | 3 (75%) |
| 40 | 3 (75%) | 3 (75%) |
| 50 | 4 (100%) | 4 (100%) |
| 65 | 4 (100%) | 4 (100%) |
| 75 | 4 (100%) | 4 (100%) |
| 85 | 2 (50%) | 2 (50%) |
Across all 20 studies, recruiting or not: 55% stop at 75 or younger and 25% at 65; 10% take children; 0% are for women only and 0% for men only; 45% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 20 of 20. search them.
- An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye DiseaseRecruitingNCT07503886Phase 21 country
- Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren DiseaseRecruitingNCT07281456Phase 21 country
- Clinical Trial for the Evaluation of Safety and Efficacy of Drop 0.4%Not yet recruitingNCT06985875Phase 3
- Low-level Light Therapy Versus Intense Pulsed Light to Prevent Iatrogenic Dry Eye Disease After Cataract SurgeryNot yet recruitingNCT07055022Not applicable1 country
- Efficacy of 0.28% Sodium Hyaluronate Eye Drops in Patient with Moderate to Severe Dry EyeEnrolling by invitationNCT06860659Phase 41 country
- Exosomes Proteomic for Sjogren's Syndrome and Dry Eye SyndromeRecruitingNCT067714271 country
- The Effect of Upper Blepharoplasty on Vision Quality in the Early Postoperative PeriodRecruitingNCT055497131 country
- Exosome-miRNA and Transcriptome Profiling of Dry Eye Syndrome and Sjogren's SyndromeNot yet recruitingNCT064750271 country
- Tolerability, Safety and Efficacy of Lubricin vs Sodium Hyaluronate Eye Drops in Subjects With Moderate Dry EyeCompletedNCT02510235Not applicable1 country
- Clinical Study for the Evaluation of Safety and Tolerability of NCP112 Eye DropsStatus unknownNCT06263998Phase 11 country
- VGH-DESJS-1 in Ocular and Oral Dryness Symptoms of Dry Eye Syndrome and Sjögren's SyndromeCompletedNCT05656196Not applicable1 country
- To Evaluate the Short-term and Long Term Efficacy of Acupuncture in Ocular and Oral Dryness Symptoms of Dry Eye SyndromeStatus unknownNCT04877483Not applicable1 country
- Ocular Manifestations in Rheumatic DiseasesCompletedNCT03753893
- Effect of Meibomian Gland Related Therapy on the Morphology of Meibomian GlandWithdrawnNCT04636372Not applicable
- Correlation of Noninvasive Tear Film Function and the Optical Quality in Mild and Moderate Dry EyeStatus unknownNCT03815539Not applicable1 country
- DRy Eye Outcome and Prescription StudyStatus unknownNCT036524151 country
- Corneal Tear Film Imaging of the Cornea Before and After Restasis TherapyStatus unknownNCT03403023Not applicable
- Performance of a Photoscreener for Vision Screening in a Haitian Pediatric PopulationWithdrawnNCT026554321 country
- Use of Autologous Serum Eye-drops as Tears in Patients With Recalcitrant Dry EyeCompletedNCT01089985Phase 11 country
- Trial to Compare the Efficacy of Systane Ultra and Refresh Drop in the Treatment of Dry Eye in Asian EyesCompletedNCT00796926Phase 31 country